Letters to the Editor

Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

Central Clinical Hospital, The Medical University of Warsaw, Warsaw, Poland;
EBMT Statistical Unit, Leiden, the Netherlands;
EBMT Leiden Study Unit, Leiden, the Netherlands;
Hospital Santa Creu i Sant Pau, Barcelona, Spain;
Hematology Department (ICHMO). Hospital Clinic de Barcelona, Barcelona, Spain;
Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland;
Unidad de Ensayos Clínicos de Hematología Pabellón A, bajo., Pamplona, Spain;
Hospital U. Marqués de Valdecilla, Santander, Spain;
University Medical Center Groningen (UMCG), Groningen, Netherlands;
Adult HSCT Unit, Newcastle, United Kingdom;
Robert Bosch Krankenhaus, Stuttgart, Germany;
Örebro University Hospital, Orebro, Sweden;
Cliniques Universitaires St. Luc, Brussels, Belgium;
ICO-Hospital Universitari Germans Trias i Pujol, Badalona, Spain;
Hospital Son Espases, IDISBA, Palma de Mallorca, Balearic Islands, Spain
University Hospital of Wales, Cardiff, United Kingdom;
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;
Oslo University Hospital, Rikshospitalet, Oslo, Norway;
Université de Franche-Comté, CHU Besançon, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France;
Unità Operativa Di Medicina Interna, Civitanove, Italy;
Adult hematology, Hôpital Necker-Enfants Malades, AP-HP.Centre Université Paris Cité, Paris, France;
University College London Hospitals NHS Trust, London, United Kingdom;
University Hospital Maastricht, Maastricht, Netherlands;
CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France;
CHU Estaing, Clermont-Ferrand University Hospital, Clermont-Ferrand, France;
University College London Hospitals NHS Trust, London, United Kingdom;
Haematologica Early view Jan 11, 2024 https://doi.org/10.3324/haematol.2023.284359